Christopher Christophi Selected Research

Dihydrolipoamide Dehydrogenase (Lipoamide Dehydrogenase)

1/2006	Impact of blood flow occlusion on liver necrosis following thermal ablation.
7/2005	Progressive microvascular injury in liver and colorectal liver metastases following laser induced focal hyperthermia therapy.
6/2005	Comparison of 980- and 1064-nm wavelengths for interstitial laser thermotherapy of the liver.
3/2005	Focal hyperthermia produces progressive tumor necrosis independent of the initial thermal effects.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Christopher Christophi Research Topics

Disease

39	Neoplasms (Cancer) 05/2022 - 04/2003
35	Neoplasm Metastasis (Metastasis) 05/2022 - 04/2003
16	Colorectal Neoplasms (Colorectal Cancer) 05/2022 - 03/2005
9	Necrosis 03/2018 - 03/2005
6	Pancreatitis 12/2009 - 01/2006
5	Pancreatic Neoplasms (Pancreatic Cancer) 01/2020 - 05/2014
5	Hyperthermia 07/2005 - 04/2003
4	Liver Failure 12/2021 - 05/2011
4	Hypoxia (Hypoxemia) 10/2018 - 11/2012
3	End Stage Liver Disease 04/2017 - 06/2005
3	Wounds and Injuries (Trauma) 10/2016 - 02/2014
3	Acute Cholecystitis 12/2014 - 02/2013
3	Carcinoma (Carcinomatosis) 06/2008 - 04/2003
2	Carcinogenesis 05/2021 - 01/2015
2	Colonic Neoplasms (Colon Cancer) 05/2020 - 12/2011
2	Adenocarcinoma 12/2017 - 07/2017
2	Melanoma (Melanoma, Malignant) 01/2016 - 06/2015
2	Residual Neoplasm 01/2016 - 05/2011
2	Hepatocellular Carcinoma (Hepatoma) 01/2015 - 01/2015
2	Body Weight (Weight, Body) 01/2013 - 01/2010
2	Reperfusion Injury 11/2007 - 08/2005
1	Postoperative Pain 01/2020
1	Acidosis 10/2018
1	Margins of Excision 01/2015
1	Hepatic Insufficiency 01/2015
1	Disease Progression 01/2015

Drug/Important Bio-Agent (IBA)

7	Captopril (Capoten)FDA LinkGeneric 05/2021 - 04/2007
6	Oxi 4503IBA 01/2016 - 07/2007
4	CateninsIBA 05/2021 - 04/2012
4	AntigensIBA 01/2019 - 01/2008
4	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 03/2018 - 06/2011
4	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 07/2017 - 04/2011
4	Biological ProductsIBA 01/2016 - 04/2003
4	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 08/2013 - 04/2007
4	salicylhydroxamic acid (SHAM)IBA 05/2013 - 04/2003
4	Oxygen (Dioxygen)IBA 12/2009 - 07/2006
4	Dihydrolipoamide Dehydrogenase (Lipoamide Dehydrogenase)IBA 01/2006 - 03/2005
3	VimentinIBA 03/2018 - 11/2012
3	BilirubinIBA 08/2011 - 05/2011
3	CytokinesIBA 05/2008 - 08/2005
3	NeodymiumIBA 01/2006 - 03/2005
3	NAD (NADH)IBA 01/2006 - 06/2005
3	QuartzIBA 10/2004 - 04/2003
2	Dihydrotachysterol (AT 10)IBA 05/2022 - 12/2011
2	CarbohydratesIBA 01/2019 - 12/2017
2	AngiotensinsIBA 10/2018 - 01/2010
2	KininsIBA 10/2018 - 01/2018
2	Biomarkers (Surrogate Marker)IBA 12/2017 - 07/2017
2	Cadherins (E-Cadherin)IBA 01/2016 - 11/2012
2	Pharmaceutical PreparationsIBA 10/2013 - 11/2012
2	gadolinium chlorideIBA 08/2013 - 07/2013
2	Irbesartan FDA LinkGeneric 06/2011 - 04/2007
2	CGP 42112AIBA 06/2011 - 01/2010
2	Angiotensin IIIBA 06/2011 - 04/2007
2	Type 2 Angiotensin ReceptorIBA 10/2010 - 01/2010
2	yttrium-aluminum-garnetIBA 01/2006 - 03/2005
2	AluminumIBA 07/2005 - 06/2005
2	YttriumIBA 07/2005 - 06/2005
1	SAR131675IBA 05/2022
1	Opioid Analgesics (Opioids)IBA 01/2020
1	Morphine (MS Contin)FDA LinkGeneric 01/2020
1	ReninIBA 10/2018
1	MucinsIBA 03/2018
1	Indicators and Reagents (Reagents)IBA 03/2018
1	GastrinsIBA 07/2017
1	big gastrinIBA 07/2017
1	Peptides (Polypeptides)IBA 10/2016
1	Immune Checkpoint InhibitorsIBA 01/2016
1	Proteoglycans (Proteoglycan)IBA 01/2016
1	ChondroitinIBA 01/2016
1	AntibodiesIBA 01/2016
1	Sunitinib (Sutent)FDA Link 01/2016
1	erucylphosphocholineIBA 01/2016
1	DNA (Deoxyribonucleic Acid)IBA 06/2015
1	MicroRNAs (MicroRNA)IBA 01/2015
1	Tumor Biomarkers (Tumor Markers)IBA 01/2015
1	Circulating MicroRNAIBA 01/2015
1	Gemcitabine FDA Link 05/2014

Therapy/Procedure

18	Therapeutics 01/2020 - 04/2003
10	Hepatectomy 05/2022 - 09/2004
8	Lasers (Laser) 01/2006 - 04/2003
5	Liver Transplantation 12/2021 - 06/2005
5	Drug Therapy (Chemotherapy) 03/2018 - 06/2008
4	Aftercare (After-Treatment) 10/2013 - 01/2004
3	Length of Stay 01/2020 - 09/2012
3	Laparotomy 01/2015 - 08/2011
3	Hyperbaric Oxygenation 11/2007 - 07/2006
3	Solid-State Lasers 06/2005 - 10/2004
2	Cholecystectomy 12/2014 - 12/2012
2	Pancreatectomy 11/2014 - 09/2012
2	Laparoscopic Cholecystectomy 10/2013 - 02/2013
2	Laser Therapy (Surgery, Laser) 05/2011 - 01/2006
2	Induced Hyperthermia (Thermotherapy) 06/2005 - 10/2004
1	Immunomodulation 05/2022
1	Intraperitoneal Injections 01/2020
1	Radiotherapy 01/2020
1	Decompression 01/2019
1	Neoadjuvant Therapy 07/2017
1	Pancreaticoduodenectomy 01/2017
1	Immunotherapy 01/2015